GSI has announced a $500,000 Innovation Cluster Accelerator grant awarded to Evergreen Bioscience Innovation (Evergreen Bio) to build a bioscience innovation cluster in the Spokane region. The Evergreen Bio is led by GSI, in partnership with SP3NW. This is a culmination of work by GSI and community partners to build our life sciences industry and further its mission to lead transformative business and community initiatives to build a robust regional economy. Read more in the media release below.
(SPOKANE, Wash.) – The Washington State Department of Commerce has awarded a $500,000 Innovation Cluster Accelerator grant to Evergreen Bioscience Innovation (Evergreen Bio) to build a bioscience innovation cluster in the Spokane region. The successful team is led by Greater Spokane Inc. in partnership with SP3NW. Washington’s Innovation Cluster Accelerator is one portion of work supported by a $15 million CARES Act Investment by the U.S. Department of Commerce Economic Development Administration.
The grant dollars will grow an industry-led business development organization and drive initiatives to build a world-class health and life science contract service industry in the region. Evergreen Bio’s mission is to make the Mountain Northwest and Washington State a magnet for companies providing and consuming expert life and health science contract research, development, and manufacturing services. They will do this by promoting industry “co-opetition,” prioritizing projects to address industry needs, and acquiring, developing, and retaining top talent.
Multiple organizations and key champions have been instrumental in the success of this award, including SP3NW, Katrina Rogers Consulting, Health Sciences and Services Authority of Spokane County, Clear Solutions Biomedical, VectorPoint Ventures, Johnston Engineering, and Alturas Analytics/Needham Scientific.
“This is a very exciting opportunity that is building on a lot of the community’s great work. Evergreen Bio is what comes next from VISION 2030, the Elson S. Floyd College of Medicine, SP3NW, and new investments from Jubilant HollisterStier and Selkirk Pharma. Contract services across the region has been identified as a gap and Evergreen Bio can lead the economic advantage of local supply chain sourcing for pharmaceutical and medical device contract services companies. We will have the opportunity to catapult our community into one of the leaders in life science services,” said Stacia Rasmussen, Health & Life Science Business Development Manager of Greater Spokane Inc.
Evergreen Bio is focusing on five key initiatives to promote bioscience innovation including a Thriving Industry, Total Mountain Northwest Supply Chain, Global Entrepreneurship Hub, 21st Century Talent, and a World-Class Cluster. Evergreen Bio will be the home for synergistic regional initiatives across these focus areas.
“Growing life sciences in Spokane requires a strong entrepreneurial community supported by financial opportunities. SP3NW is proud to be a part of the team bringing Evergreen Bio into existence. We already have strong interest from the private sector, entrepreneurs, finance, government, and education from current work with parallel aims of the FIRE grant programs. The grant will give us the ability to grow on this success,” said Michaele Armstrong, Associate Director of SP3NW.